Yale University, one of the leading international higher education rankings, presents Catalin Carrico on its website as a specialist in RNA mechanisms. He was co-founder and CEO of RNARx from 2006 to 2013 and is currently Senior Vice President of BioNTech RNA Pharmaceuticals.
His work is a cornerstone in developing a vaccine against Covid-19. She holds US patents for the use of non-immunogenic nucleoside-modified RNA, a technology licensed by Pfizer and Moderna to develop their vaccines.
Chances of a Nobel Prize
His contribution to fighting the pandemic makes him and his colleague Drew Wiseman – who also received recognition from Yale University – eligible for the Nobel Prize. As praised by Catalin Kariko,
His personal history of endurance and resilience became widely known in the time of the pandemic, and inspired many.
Since the use of the mRNA vaccine, Katalin Karikó has become a recognized and sought-after figure and has been featured in major publications and in the TIME 100 list. Among the celebrities he thanked even Liam Neeson.
Among the personalities to win an honorary doctorate from Yale University this year and distinguished in their field are musicians, journalists, diplomats, civil servants, historians, lawyers, medical researchers, biochemists, immunologists, and sociologists.
Katalin Cariko, alumna, honorary physician, and research professor at the University of Szeged, has become an honorary citizen of the sixth most prestigious higher education institution with an honors degree from Yale University.
(Cover photo: Katalin Cariko on December 17, 2021. Photo: Tamás Kaszás/Index)